Intended for healthcare professionals

  1. Research
  2. Campylobacter...
  3. Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.
Research Article

Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.

Br Med J (Clin Res Ed) 1986; 293 doi: https://doi.org/10.1136/bmj.293.6548.645 (Published 13 September 1986) Cite this as: Br Med J (Clin Res Ed) 1986;293:645

Related articles

  • No related articles found.

See more

Cited by...

  • In Vitro and In Vivo Activities of HPi1, a Selective Antimicrobial against Helicobacter pylori
  • Cholesterol Enhances Helicobacter pylori Resistance to Antibiotics and LL-37
  • In Vitro and In Vivo Antibacterial Activities of TAK-083, an Agent for Treatment of Helicobacter pyloriInfection
  • Antimicrobial Therapies for Helicobacter pylori Infection in Gnotobiotic Piglets
Back to top